Rosalind Advisors, Inc. Q2 2025 Filing
Filed August 14, 2025
Portfolio Value
$210.9B
Holdings
37
Report Date
Q2 2025
Filing Type
13F-HR
All Holdings (37 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | DCTHDELCATH SYS INC | 3,300,389 | $33.0B | 15.65% | |
| 2 | FRXFENNEC PHARMACEUTICALS INC | 2,045,644 | $17.0B | 8.05% | |
| 3 | CYTKCYTOKINETICS INC | 400,000 | $13.2B | 6.27% | |
| 4 | OCULOCULAR THERAPEUTIX INC | 1,218,700 | $11.3B | 5.36% | |
| 5 | IDYAIDEAYA BIOSCIENCES INC | 511,132 | $10.7B | 5.09% | |
| 6 | XERSXERIS BIOPHARMA HOLDINGS INC | 2,155,594 | $10.1B | 4.77% | |
| 7 | VRDNVIRIDIAN THERAPEUTICS INC | 700,000 | $9.8B | 4.64% | |
| 8 | VRNAVERONA PHARMA PLC | 100,000 | $9.5B | 4.48% | |
| 9 | VSTMVERASTEM INC | 2,043,563 | $8.5B | 4.02% | |
| 10 | REPLREPLIMUNE GROUP INC | 900,000 | $8.4B | 3.96% | |
| 11 | MDWDMEDIWOUND LTD | 407,061 | $7.9B | 3.74% | |
| 12 | MYOMYOMO INC | 3,595,788 | $7.8B | 3.68% | |
| 13 | RZLTREZOLUTE INC | 1,741,211 | $7.8B | 3.68% | |
| 14 | URGNUROGEN PHARMA LTD | 542,366 | $7.4B | 3.52% | |
| 15 | HELPCYBIN INC | 810,918 | $6.8B | 3.23% | |
| 16 | YB4PSAVARA INC | 2,654,944 | $6.1B | 2.87% | |
| 17 | NSPRINSPIREMD INC | 2,289,099 | $5.2B | 2.46% | |
| 18 | CGONCG ONCOLOGY INC | 192,974 | $5.0B | 2.38% | |
| 19 | PRNPROFOUND MED CORP | 692,185 | $4.1B | 1.94% | |
| 20 | PHVSPHARVARIS N V | 223,627 | $3.9B | 1.87% | |
| 21 | PYPDPOLYPID LTD | 975,462 | $3.4B | 1.63% | |
| 22 | BRD1EURMIND MEDICINE MINDMED INC | 420,000 | $2.7B | 1.29% | |
| 23 | KALVKALVISTA PHARMACEUTICALS INC | 157,725 | $1.8B | 0.85% | |
| 24 | INMBINMUNE BIO INC | 1,033,200 | $1.8B | 0.84% | Put |
| 25 | TRVITREVI THERAPEUTICS INC | 300,000 | $1.6B | 0.78% | |
| 26 | CMPSCOMPASS PATHWAYS PLC | 482,651 | $1.4B | 0.64% | |
| 27 | TLPHTALPHERA INC | 2,003,939 | $922.2M | 0.44% | |
| 28 | BFRIBIOFRONTERA INC | 976,448 | $694.7M | 0.33% | |
| 29 | URGNUROGEN PHARMA LTD | 100,000 | $600.0M | 0.28% | Call |
| 30 | KURAKURA ONCOLOGY INC | 100,000 | $577.0M | 0.27% | |
| 31 | LVLNSPDR SERIES TRUST | 550,000 | $534.0M | 0.25% | Put |
| 32 | REPLREPLIMUNE GROUP INC | 231,800 | $515.6M | 0.24% | Call |
| 33 | SPYSPDR S&P 500 ETF TR | 250,000 | $432.5M | 0.21% | Put |
| 34 | ATYRATYR PHARMA INC | 223,000 | $271.1M | 0.13% | Put |
| 35 | OVIDOVID THERAPEUTICS INC | 500,000 | $164.9M | 0.08% | |
| 36 | IDYAIDEAYA BIOSCIENCES INC | 20,000 | $68.0M | 0.03% | Call |
| 37 | CRNXCRINETICS PHARMACEUTICALS IN | 52,700 | $58.0M | 0.03% | Call |